Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment

PURPOSE: In the treatment of patients with metastatic cancer, the current paradigm states that metastasis-directed therapy does not prolong life. This paradigm forms the basis of clinical trial null hypotheses, where trials are built to test the null hypothesis that patients garner no overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarborough, Jessica A., Tom, Martin C., Kattan, Michael W., Scott, Jacob G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122026/
https://www.ncbi.nlm.nih.gov/pubmed/33484786
http://dx.doi.org/10.1016/j.ijrobp.2020.12.044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122026/
https://www.ncbi.nlm.nih.gov/pubmed/33484786
http://dx.doi.org/10.1016/j.ijrobp.2020.12.044

Ejemplares similares